Elizabeth Berry‐Kravis

26.9k total citations · 3 hit papers
345 papers, 15.8k citations indexed

About

Elizabeth Berry‐Kravis is a scholar working on Genetics, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Elizabeth Berry‐Kravis has authored 345 papers receiving a total of 15.8k indexed citations (citations by other indexed papers that have themselves been cited), including 249 papers in Genetics, 177 papers in Cognitive Neuroscience and 110 papers in Molecular Biology. Recurrent topics in Elizabeth Berry‐Kravis's work include Genetics and Neurodevelopmental Disorders (241 papers), Autism Spectrum Disorder Research (175 papers) and Neuroscience of respiration and sleep (41 papers). Elizabeth Berry‐Kravis is often cited by papers focused on Genetics and Neurodevelopmental Disorders (241 papers), Autism Spectrum Disorder Research (175 papers) and Neuroscience of respiration and sleep (41 papers). Elizabeth Berry‐Kravis collaborates with scholars based in United States, Canada and Switzerland. Elizabeth Berry‐Kravis's co-authors include Randi J. Hagerman, Debra E. Weese‐Mayer, Flora Tassone, Paul J. Hagerman, Maureen A. Leehey, Lili Zhou, David Hessl, Casey M. Rand, Sébastien Jacquemont and Jim Grigsby and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Elizabeth Berry‐Kravis

333 papers receiving 15.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fragile X Premutation Tremor/Ataxia Syndrome: Molecular, Clinical, and Neuroimaging Correlates

2003 556 citations Sébastien Jacquemont, Randi J. Hagerman et al. profile →
Fragile X syndrome

2017 466 citations Randi J. Hagerman, Elizabeth Berry‐Kravis et al. profile →
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study

2023 106 citations Jeffrey L. Neul, Alan K. Percy et al. profile →

Peers

Countries citing papers authored by Elizabeth Berry‐Kravis

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Berry‐Kravis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Berry‐Kravis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Berry‐Kravis more than expected).

Fields of papers citing papers by Elizabeth Berry‐Kravis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Berry‐Kravis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Berry‐Kravis. The network helps show where Elizabeth Berry‐Kravis may publish in the future.

Co-authorship network of co-authors of Elizabeth Berry‐Kravis

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Berry‐Kravis. A scholar is included among the top collaborators of Elizabeth Berry‐Kravis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Berry‐Kravis. Elizabeth Berry‐Kravis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Convergent Validity of the Fine Motor, Speech, and Cognitive Domains of the 5-Domain Niemann-Pick Disease Type C Clinical Severity Scale 2025 ·Journal of Child Neurology ·Cristan Farmer, Monica Lewis, Nicole Y. Farhat, Kenneth E. Robbins, Lisa Joseph, (unknown), Simona Bianconi, Anne Hoffmann, (unknown), (unknown), Audrey Thurm, (unknown), Elizabeth Berry‐Kravis	0
2	Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study 2024 ·Med ·Alan K. Percy, Jeffrey L. Neul, Tim A. Benke, Elizabeth Berry‐Kravis, Daniel G. Glaze, Eric D. Marsh, (unknown), Kathie M. Bishop, James M. Youakim	15
3	Cerebrospinal Fluid and Serum Neuron‐Specific Enolase in Niemann‐Pick Disease Type C1 2024 ·American Journal of Medical Genetics Part A ·(unknown), (unknown), (unknown), (unknown), Kenneth E. Robbins, Elizabeth Berry‐Kravis, Forbes D. Porter	0
4	Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study 2024 ·Med ·Alan K. Percy, Jeffrey L. Neul, Tim A. Benke, Elizabeth Berry‐Kravis, Daniel G. Glaze, Eric D. Marsh, Amy Barrett, (unknown), Kathie M. Bishop, James M. Youakim	9
5	Proteomic Profiling of Angelman Syndrome for Disease-associated Biomarker Discovery (P8-8.001) 2024 ·Neurology ·Rachael E. Hawtin, Julien Couthouis, (unknown), Grace Wang, Jennifer Panagoulias, Larry Gold, Sean C. Daugherty, (unknown), Elizabeth Berry‐Kravis, Allyson Berent	1
6	A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases 2024 ·Nature Communications ·(unknown), Joseph G. Gleeson, Laurence Mignon, (unknown), Winston X. Yan, (unknown), Scott Demarest, Elizabeth Berry‐Kravis, Richard S. Finkel, (unknown), Samuel G. Finlayson, Erika F. Augustine, Gholson J. Lyon, Rebecca Schüle, Timothy W. Yu	7
7	Antisense oligonucleotide rescue of CGG expansion–dependent FMR1 mis-splicing in fragile X syndrome restores FMRP 2023 ·Proceedings of the National Academy of Sciences ·Sneha Shah, (unknown), (unknown), Jonathan Lee, Jonathan K. Watts, Elizabeth Berry‐Kravis, Joel D. Richter	26
8	Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett Syndrome 2023 ·Pediatric Neurology ·Jeffrey L. Neul, Alan K. Percy, Tim A. Benke, Elizabeth Berry‐Kravis, Daniel G. Glaze, Sarika U. Peters, Eric D. Marsh, (unknown), Kathie M. Bishop, James M. Youakim	13
9	Sensitivity of the NIH Toolbox to Detect Cognitive Change in Individuals With Intellectual and Developmental Disability 2022 ·Neurology ·(unknown), Aaron J. Kaat, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Karen Riley, Elizabeth Berry‐Kravis, Keith F. Widaman, Richard Gershon, David Hessl	6
10	Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity 2020 ·Journal of Neurodevelopmental Disorders ·Leonard Abbeduto, Elizabeth Berry‐Kravis, Audra Sterling, Stephanie L. Sherman, Jamie O. Edgin, Andrea McDuffie, Anne Hoffmann, Debra Hamilton, Michael N. Nelson, (unknown), Angela John Thurman	39
11	Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome 2020 ·Brain Sciences ·James Robert Brašić, Ayon Nandi, David Russell, Danna Jennings, Olivier Barret, Anil Mathur, Keith J. Slifer, Thomas W. Sedlak, (unknown), (unknown), Pankhuri Vyas, John Seibyl, Elizabeth Berry‐Kravis, Dean F. Wong, Dejan B. Budimirovic	12
12	Psychometric Study of the Social Responsiveness Scale in Phelan–McDermid Syndrome 2020 ·Autism Research ·(unknown), Alan Weinberg, Jonathan Templin, Cristan Farmer, (unknown), Jordana Weissman, Paige M. Siper, Jennifer H. Foss‐Feig, Maria del Pilar Trelles, Jonathan A. Bernstein, Joseph D. Buxbaum, Elizabeth Berry‐Kravis, Craig M. Powell, Mustafa Şahin, Latha Soorya, Audrey Thurm, Alexander Kolevzon	16
13	Congenital central hypoventilation syndrome: Severe disease caused by co‐occurrence of two PHOX2B variants inherited separately from asymptomatic family members 2019 ·American Journal of Medical Genetics Part A ·Yakov Sivan, Amy Zhou, Lawrence J. Jennings, Elizabeth Berry‐Kravis, Min Yu, Lili Zhou, Casey M. Rand, Debra E. Weese‐Mayer	7
14	Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid Syndrome 2018 ·Pediatric Neurology ·Siddharth Srivastava, Benoît Scherrer, Anna K. Prohl, Rajna Filip‐Dhima, Kush Kapur, Alexander Kolevzon, Joseph D. Buxbaum, Elizabeth Berry‐Kravis, Latha Soorya, Audrey Thurm, Craig M. Powell, Jonathan A. Bernstein, Simon K. Warfield, Mustafa Şahin	16
15	Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment 2017 ·PEDIATRICS ·Walter E. Kaufmann, Sharon A. Kidd, Howard Andrews, Dejan B. Budimirovic, Amy Esler, Barbara Haas‐Givler, Tracy Stackhouse, Catharine Riley, Georgina Peacock, Stephanie L. Sherman, W. Ted Brown, Elizabeth Berry‐Kravis	186
16	Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results 2017 ·Neuropsychopharmacology ·(unknown), Eriene Youssef, Elizabeth Berry‐Kravis, Christian Czech, Randi J. Hagerman, David Hessl, (unknown), Michael Rabbia, Dennis Deptula, (unknown), (unknown), (unknown), Lothar Lindemann, Moritz Marcinowski, Rachel Langland, Carsten Horn, Paulo Fontoura, Luca Santarelli, Jorge A. Quiroz	93
17	Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials 2016 ·Science Translational Medicine ·Elizabeth Berry‐Kravis, Vincent des Portes, Randi J. Hagerman, Sébastien Jacquemont, Perrine Charles, Jeannie Visootsak, (unknown), K. Rérat, Barbara Koumaras, Liansheng Zhu, Gottfried Maria Barth, Thomas Jaecklin, George Apostol, Florian von Raison	185
18	Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series 2016 ·The Cerebellum ·(unknown), Maureen A. Leehey, Olga Klepitskaya, Christopher M. Filley, Raj C. Shah, Benzi M. Kluger, Elizabeth Berry‐Kravis, Elaine Spector, Flora Tassone, Deborah A. Hall	17
19	Absence of mutations in HCRT, HCRTR1 and HCRTR2 in patients with ROHHAD 2015 ·Respiratory Physiology & Neurobiology ·Sarah Barclay, Casey M. Rand, Paul A. Gray, William T. Gibson, Richard J. A. Wilson, Elizabeth Berry‐Kravis, Diego Ize-Ludlow, N. Torben Bech‐Hansen, Debra E. Weese‐Mayer	14
20	A 6-Week, Randomized, Multicenter, Double-Blind, Parallel, Flexed- and Fixed-Dose Study of MDX (Metadoxine Extended-Release; MG01CI) Compared With Placebo in Adolescents and Adults With Fragile X Syndrome 2015 ·Elizabeth Berry‐Kravis	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact